Leukapheresis Market 2020: Worldwide Industry Production, Sales, Share, Future Trends and Forecast 2023

2020 Research Report on Global Leukapheresis Market is a professional and comprehensive report on the Leukapheresis industry.

#Download Free PDF Sample Brochure of report Global Leukapheresis Market 2020 across with 194 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1612511

Key Players: Asahi Kasei Medical (Japan), Fresenius (Germany), Haemonetics (US), Terumo BCT (US), STEMCELL Technologies (Canada), and Macopharma (France). Some prominent players in the leukopaks market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US).

"The leukapheresis products and leukopaks markets are projected to grow at a CAGR of 7.4% and 46.4%, respectively."

The leukapheresis products market is expected to reach USD 27.7 million by 2023 from an estimated USD 19.4 million in 2018, at a CAGR of 7.4%.The leukopaks market is expected to reach USD 445.6million by 2023, at a CAGR of 46.4%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. However, the high cost of therapeutic leukapheresis and leukopaks and stringent donor recruitment criteria are restraining the growth of this market to a certain extent.

"The leuko reduction filters segment is expected to register the highest CAGR during the forecast period."

By type, the leukapheresis products market is segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment is further sub segmented into apheres is devices, leukapheresis columns & cell separators, and leuko reduction filters. The leukoreduction filters segment is expected to register the highest CAGR during the forecast period. This high growth-rate can be attributed to the increasing adoption of leuko reduction filters by researchers.

"The isolated PBMCs segment is expected to register the highest CAGR during the forecast period."

On the basis of type, the leukopaks market is segmented into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. The isolated PBMCs segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing focus of researchers on cell-based therapies including CAR-T therapy targeted development.

"Asia Pacific is projected to witness the highest growth during the forecast period."

In 2017, the Asia Pacific accounted for the largest share of the global leukapheresis market. This regional segment is also estimated to grow at the highest CAGR during the forecast period. The presence of a large number of pharma and biotech companies and research institutes in China and India and improving life science research infrastructure in several APAC countries are the major factors driving the growth of this regional market.

Place a Direct Purchase Order and Get Flat 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=1612511

In the end, the Global Leukapheresis Market report's conclusion part notes the estimation of the industry veterans.

Connect Us for more information at sales@reportsandreports.com or Call Us + 1 888 391 5441.

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.